Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy JF Navarro-González, C Mora-Fernández, MM De Fuentes, ... Nature Reviews Nephrology 7 (6), 327-340, 2011 | 1224 | 2011 |
The role of inflammatory cytokines in diabetic nephropathy JF Navarro-Gonzalez, C Mora-Fernandez Journal of the American Society of Nephrology 19 (3), 433-442, 2008 | 1215 | 2008 |
Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus JF Navarro, C Mora, M Macıéa, J Garcıéa American Journal of Kidney Diseases 42 (1), 53-61, 2003 | 471 | 2003 |
Role of inflammation in diabetic complications JF Navarro, C Mora Nephrology dialysis transplantation 20 (12), 2601-2604, 2005 | 355 | 2005 |
Inflammatory cytokines in diabetic nephropathy J Donate-Correa, E Martín-Núñez, M Muros-de-Fuentes, ... Journal of diabetes research 2015, 2015 | 306 | 2015 |
Pathogenic perspectives for the role of inflammation in diabetic nephropathy A Rivero, C Mora, M Muros, J García, H Herrera, JF Navarro-González Clinical science 116 (6), 479-492, 2009 | 306 | 2009 |
Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration JF Navarro, FJ Milena, C Mora, C León, J García American journal of nephrology 26 (6), 562-570, 2007 | 292 | 2007 |
Inflammation and diabetic nephropathy C Mora, JF Navarro Current diabetes reports 6 (6), 463-468, 2006 | 287 | 2006 |
The role of TNF-α in diabetic nephropathy: pathogenic and therapeutic implications JF Navarro, C Mora-Fernández Cytokine & growth factor reviews 17 (6), 441-450, 2006 | 267 | 2006 |
Inflammation in diabetic kidney disease RE Pérez-Morales, MD Del Pino, JM Valdivielso, A Ortiz, ... Nephron 143 (1), 12-16, 2019 | 224 | 2019 |
Effect of pentoxifylline on renal function and urinary albumin excretion in patients with diabetic kidney disease: the PREDIAN trial JF Navarro-González, C Mora-Fernández, MM de Fuentes, J Chahin, ... Journal of the American Society of Nephrology 26 (1), 220-229, 2015 | 224 | 2015 |
Diabetic kidney disease: from physiology to therapeutics C Mora‐Fernández, V Domínguez‐Pimentel, MM de Fuentes, JL Górriz, ... The Journal of physiology 592 (18), 3997-4012, 2014 | 223 | 2014 |
Reviews: Clinical Implications of Disordered Magnesium Homeostasis in Chronic Renal Failure and Dialysis JF Navarro‐González, C Mora‐Fernández, J García‐Pérez Seminars in dialysis 22 (1), 37-44, 2009 | 220 | 2009 |
Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: effects of pentoxifylline administration JF Navarro, C Mora, A Rivero, E Gallego, J Chahin, M Macía, ML Méndez, ... American Journal of Kidney Diseases 33 (3), 458-463, 1999 | 197 | 1999 |
Urinary tumour necrosis factor-α excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients JF Navarro, C Mora, M Muros, J García Nephrology Dialysis Transplantation 21 (12), 3428-3434, 2006 | 195 | 2006 |
Diabetes, inflammation, proinflammatory cytokines, and diabetic nephropathy JF Navarro, C Mora The Scientific World Journal 6, 908-917, 2006 | 186 | 2006 |
Reduced Klotho is associated with the presence and severity of coronary artery disease JF Navarro-González, J Donate-Correa, MM de Fuentes, ... Heart 100 (1), 34-40, 2014 | 178 | 2014 |
Tumor necrosis factor-α gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition JJ Navarro, FF Milena, C Mora, C León, F Claverie, C Flores, J García Kidney International 68, S98-S102, 2005 | 172 | 2005 |
Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: a short-term, randomized, controlled trial JF Navarro, C Mora, M Muros, J García Journal of the American Society of Nephrology 16 (7), 2119-2126, 2005 | 164 | 2005 |
The role of inflammation as a pathogenic factor in the development of renal disease in diabetes C Mora, JF Navarro Current Diabetes Reports 5 (6), 399-401, 2005 | 160 | 2005 |